OK, last response to you. You own IMU so you would understand...

OK, last response to you.

You own IMU so you would understand when I say this. Most, NOT ALL, but most medical stocks products would not sell strongly without an FDA approval. Like IMU, once PainChek receives the FDA approval, sales will start to grow strongly and market cap will eventually grow as well. The same will happen with IMU. For example, IMU's Hervaxx has been proven to be better than Herceptin (which is FDA approved) in treating gastric cancer for a few years already. This happened before you even become a shareholder. Yet, not a single sale while Herceptin is raking billions every year. The fact in the life of a medical company is simply this. Without FDA stamp of approval, most jurisdictions and companies would be reluctant to use their product and it would take a lot of convincing.

So there is no need for you to continue to put PCK down. The day it gets its FDA approval, you will be the loser who missed out.

Have a good day.